Verapamil Hydrochloride Injection, Solution
Product Images NDC 51662-1549

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 51662-1549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (51662 1549 1 Serialized Vial Labeling)

FDA Label Image

Vial Label (51662 1549 1 Vial Label)

This is a description of a medication with the NDC code 55150-342-01, manufactured in India for AuroMedics Pharma LLC. The medication comes in a 2mL single-dose vial and contains 5mg of the active ingredient, which is intended for intravenous use only. The code TSIDRUGS/ 132010 P1422944 is also provided, along with the warning to protect the medication from light.*

FDA Label Image

Adverse (Adverse)

This text provides information on the management of adverse reactions, including symptomatic hypotension, bradycardia, AV block, asystole, and rapid ventricular rate. The text suggests various medications such as calcium chloride, norepinephrine bitartrate, isoproterenal HCl, dopamine, atropine, and lidocaine to manage the condition depending on its severity. Intravenous fluids are also administered in a slow-drip method. It is highlighted that the actual treatment and dosage should rely on the clinician's judgment and experience.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.